These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Thalidomide in oral Crohn's disease refractory to conventional medical treatment. Odeka EB; Miller V J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):250-1. PubMed ID: 9252926 [No Abstract] [Full Text] [Related]
5. Crohn's disease of the oesophagus. A case report. Freson M; Kottler RE; Wright JP S Afr Med J; 1984 Sep; 66(11):417-8. PubMed ID: 6484767 [TBL] [Abstract][Full Text] [Related]
6. Thalidomide in refractory vulvar ulcerations associated with Crohn's disease. Kolivras A; De Maubeuge J; André J; Song M Dermatology; 2003; 206(4):381-3. PubMed ID: 12771492 [TBL] [Abstract][Full Text] [Related]
7. Re: Disappearance of Crohn's ulcers in the terminal ileum after thalidomide therapy. Can J Gastroenterol 2004; 18(2): 101-104. Cohen LB Can J Gastroenterol; 2004 Jun; 18(6):419; author reply 419. PubMed ID: 15230268 [No Abstract] [Full Text] [Related]
8. Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis. Hegarty A; Hodgson T; Porter S Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 May; 95(5):576-85. PubMed ID: 12738949 [TBL] [Abstract][Full Text] [Related]
9. [Esophageal Crohn's disease]. Gil-Simón P; Barrio J; Saracíbar E; Pérez-Miranda M; Julián L; Antonio Gil Ruiz J; Caro-Patón A Gastroenterol Hepatol; 2008 Feb; 31(2):108-9. PubMed ID: 18279653 [No Abstract] [Full Text] [Related]
11. A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease. Mansfield JC; Parkes M; Hawthorne AB; Forbes A; Probert CS; Perowne RC; Cooper A; Zeldis JB; Manning DC; Hawkey CJ Aliment Pharmacol Ther; 2007 Aug; 26(3):421-30. PubMed ID: 17635377 [TBL] [Abstract][Full Text] [Related]
12. Prolonged use of gastrostomy for enteral hyperalimentation in children with Crohn's disease. Israel DM; Hassall E Am J Gastroenterol; 1995 Jul; 90(7):1084-8. PubMed ID: 7611202 [TBL] [Abstract][Full Text] [Related]
13. Thalidomide and refractory Crohn's disease: what is in the future? Ng SC J Clin Gastroenterol; 2014 Jul; 48(6):476-7. PubMed ID: 24781387 [No Abstract] [Full Text] [Related]
14. Editorial: is thalidomide a good option for patients with refractory Crohn's disease? Rogler G Aliment Pharmacol Ther; 2015 Apr; 41(8):785-6. PubMed ID: 25781038 [No Abstract] [Full Text] [Related]
15. Thalidomide improves clinical remission in children with Crohn's disease. Harbour S; Brown N Arch Dis Child Educ Pract Ed; 2015 Apr; 100(2):111. PubMed ID: 25721487 [No Abstract] [Full Text] [Related]
16. Editorial: is thalidomide a good option for patients with refractory Crohn's disease? Authors' reply. Gerich M; Yoon J; Vasiliauskas E Aliment Pharmacol Ther; 2015 Apr; 41(8):786. PubMed ID: 25781039 [No Abstract] [Full Text] [Related]
17. Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies. Plamondon S; Ng SC; Kamm MA Aliment Pharmacol Ther; 2007 Mar; 25(5):557-67. PubMed ID: 17305756 [TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas. Ng SC; Plamondon S; Gupta A; Burling D; Swatton A; Vaizey CJ; Kamm MA Am J Gastroenterol; 2009 Dec; 104(12):2973-86. PubMed ID: 19755971 [TBL] [Abstract][Full Text] [Related]
19. Successful treatment of metastatic Crohn's disease with cyclosporine. Carranza DC; Young L J Drugs Dermatol; 2008 Aug; 7(8):789-91. PubMed ID: 18720698 [TBL] [Abstract][Full Text] [Related]
20. Orofacial granulomatosis in children: think about Crohn's disease. Lazzerini M; Martelossi S; Cont G; Bersanini C; Ventura G; Fontana M; Zuin G; Ventura A; Taddio A Dig Liver Dis; 2015 Apr; 47(4):338-41. PubMed ID: 25618553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]